Abstract Background Cardiovascular diseases (CVDs) are the leading cause of global mortality and a major contributor to disability. According European Disease Statistics, in 2017 there were 108.7 million people living with CVDs Europe resulting about 4,681 disability-adjusted life years per 100,000 inhabitants. Among these, ischaemic heart cerebrovascular (IH&CBD) represent highest burden t...

background there are different risk factors that affect the intensive care unit (icu) stay after cardiac surgery. objectives the aim of this study was to evaluate possible risk factors influencing prolonged icu stay in a large referral hospital. patients and methods we conducted a case-control study to determinate causes of prolonged icu stay in 280 adult patients undergoing cardiac surgery in ...

OBJECTIVE Palivizumab has been shown to reduce the number of respiratory syncytial virus (RSV)-related hospitalizations by 45% in children with congenital heart disease (CHD). The American Academy of Pediatrics has recommended that infants with hemodynamically significant CHD be considered for palivizumab. However, the economic implications of palivizumab prophylaxis in the CHD population have ...

OBJECTIVE The objective of this study was to evaluate the impact of medication adherence on healthcare utilization and cost for 4 chronic conditions that are major drivers of drug spending: diabetes, hypertension, hypercholesterolemia, and congestive heart failure. RESEARCH DESIGN The authors conducted a retrospective cohort observation of patients who were continuously enrolled in medical an...

Objective: To evaluate the direct medical cost of hospital admissions for patients with varicella (i.e., chickenpox) to assess the cost burden of varicella from a health care perspective for ultimate use in health economics studies in Turkey. Methods: Records of children hospitalized with varicella at the Bakirkoy Maternity and Children’s Hospital between November of 2006 and June of 2011 were ...

BACKGROUND Community-acquired pneumonia (CAP) is a serious clinical problem, causing hospitalization in about 20% of cases and death in up to 16% of hospitalized patients. Work-loss cost estimates indicate that the treatment of CAP also has a large economic impact. The purpose of this study was to assess the medical and prescription drug (treatment) costs of managing CAP in an employed populati...